Loading…
Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer
The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described...
Saved in:
Published in: | Journal of applied polymer science 2001-11, Vol.82 (8), p.1844-1849 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23 |
---|---|
cites | cdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23 |
container_end_page | 1849 |
container_issue | 8 |
container_start_page | 1844 |
container_title | Journal of applied polymer science |
container_volume | 82 |
creator | Meirim, M. G. Neuse, E. W. N'Da, D. D. |
description | The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley & Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001 |
doi_str_mv | 10.1002/app.2027 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21470103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>582407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhq2qlbqlSPwEX1r14mVsJ3FyhFVLEbSAWsTRcpwJa3A-sBPB3vrTMdpV6aWnGWme99HoJeSAw5IDiEMzjksBQr0hCw6VYlkhyrdkkU6clVWVvycfYrwD4DyHYkH-rEwIDgOrh7lvaIfTepgCPpkJl_R0SW_SElgc_Fx7pOPgNyaOJkymcw2yf3Fqh_5uvk1bpI9uWlOMKUq96-8jdT2d1tt8l3xNmG9p8lgMH8m71viI-7u5R66_ff29-s7OL05OV0fnzMpCKFbLvBWVgczwBhF53uaASmVFXjSlraoajCpkCU1m67yuLVphbdmWHFFmbS3kHvm89Y5heJjTb7pz0aL3psdhjlrwTAEHmcAvW9CGIcaArR6D60zYaA76pWKdKtYvFSf0085pojW-Daa3Lr7yGSgQGU8c23KPzuPmvz59dHm58-54lyp8-subcK8LJVWub36e6Cv5A34dF2dayWceJZx8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21470103</pqid></control><display><type>article</type><title>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</title><source>Wiley</source><creator>Meirim, M. G. ; Neuse, E. W. ; N'Da, D. D.</creator><creatorcontrib>Meirim, M. G. ; Neuse, E. W. ; N'Da, D. D.</creatorcontrib><description>The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley & Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001</description><identifier>ISSN: 0021-8995</identifier><identifier>EISSN: 1097-4628</identifier><identifier>DOI: 10.1002/app.2027</identifier><identifier>CODEN: JAPNAB</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Agents ; antifolate agent ; Applied sciences ; Aromatic compounds ; bioavailability ; Biological and medical sciences ; Diseases ; Esters ; Exact sciences and technology ; General pharmacology ; macromolecular carrier ; Macromolecules ; Medical sciences ; methotrexate ; Natural polymers ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Physicochemistry of polymers ; Polyamides ; polymer-drug conjugation ; Proteins ; Purification ; Reaction kinetics ; Solubility ; Water</subject><ispartof>Journal of applied polymer science, 2001-11, Vol.82 (8), p.1844-1849</ispartof><rights>Copyright © 2001 John Wiley & Sons, Inc.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</citedby><cites>FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14070241$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Meirim, M. G.</creatorcontrib><creatorcontrib>Neuse, E. W.</creatorcontrib><creatorcontrib>N'Da, D. D.</creatorcontrib><title>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</title><title>Journal of applied polymer science</title><addtitle>J. Appl. Polym. Sci</addtitle><description>The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley & Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001</description><subject>Agents</subject><subject>antifolate agent</subject><subject>Applied sciences</subject><subject>Aromatic compounds</subject><subject>bioavailability</subject><subject>Biological and medical sciences</subject><subject>Diseases</subject><subject>Esters</subject><subject>Exact sciences and technology</subject><subject>General pharmacology</subject><subject>macromolecular carrier</subject><subject>Macromolecules</subject><subject>Medical sciences</subject><subject>methotrexate</subject><subject>Natural polymers</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemistry of polymers</subject><subject>Polyamides</subject><subject>polymer-drug conjugation</subject><subject>Proteins</subject><subject>Purification</subject><subject>Reaction kinetics</subject><subject>Solubility</subject><subject>Water</subject><issn>0021-8995</issn><issn>1097-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kE1P3DAQhq2qlbqlSPwEX1r14mVsJ3FyhFVLEbSAWsTRcpwJa3A-sBPB3vrTMdpV6aWnGWme99HoJeSAw5IDiEMzjksBQr0hCw6VYlkhyrdkkU6clVWVvycfYrwD4DyHYkH-rEwIDgOrh7lvaIfTepgCPpkJl_R0SW_SElgc_Fx7pOPgNyaOJkymcw2yf3Fqh_5uvk1bpI9uWlOMKUq96-8jdT2d1tt8l3xNmG9p8lgMH8m71viI-7u5R66_ff29-s7OL05OV0fnzMpCKFbLvBWVgczwBhF53uaASmVFXjSlraoajCpkCU1m67yuLVphbdmWHFFmbS3kHvm89Y5heJjTb7pz0aL3psdhjlrwTAEHmcAvW9CGIcaArR6D60zYaA76pWKdKtYvFSf0085pojW-Daa3Lr7yGSgQGU8c23KPzuPmvz59dHm58-54lyp8-subcK8LJVWub36e6Cv5A34dF2dayWceJZx8</recordid><startdate>20011121</startdate><enddate>20011121</enddate><creator>Meirim, M. G.</creator><creator>Neuse, E. W.</creator><creator>N'Da, D. D.</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20011121</creationdate><title>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</title><author>Meirim, M. G. ; Neuse, E. W. ; N'Da, D. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Agents</topic><topic>antifolate agent</topic><topic>Applied sciences</topic><topic>Aromatic compounds</topic><topic>bioavailability</topic><topic>Biological and medical sciences</topic><topic>Diseases</topic><topic>Esters</topic><topic>Exact sciences and technology</topic><topic>General pharmacology</topic><topic>macromolecular carrier</topic><topic>Macromolecules</topic><topic>Medical sciences</topic><topic>methotrexate</topic><topic>Natural polymers</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemistry of polymers</topic><topic>Polyamides</topic><topic>polymer-drug conjugation</topic><topic>Proteins</topic><topic>Purification</topic><topic>Reaction kinetics</topic><topic>Solubility</topic><topic>Water</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meirim, M. G.</creatorcontrib><creatorcontrib>Neuse, E. W.</creatorcontrib><creatorcontrib>N'Da, D. D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Journal of applied polymer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meirim, M. G.</au><au>Neuse, E. W.</au><au>N'Da, D. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</atitle><jtitle>Journal of applied polymer science</jtitle><addtitle>J. Appl. Polym. Sci</addtitle><date>2001-11-21</date><risdate>2001</risdate><volume>82</volume><issue>8</issue><spage>1844</spage><epage>1849</epage><pages>1844-1849</pages><issn>0021-8995</issn><eissn>1097-4628</eissn><coden>JAPNAB</coden><abstract>The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley & Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/app.2027</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-8995 |
ispartof | Journal of applied polymer science, 2001-11, Vol.82 (8), p.1844-1849 |
issn | 0021-8995 1097-4628 |
language | eng |
recordid | cdi_proquest_miscellaneous_21470103 |
source | Wiley |
subjects | Agents antifolate agent Applied sciences Aromatic compounds bioavailability Biological and medical sciences Diseases Esters Exact sciences and technology General pharmacology macromolecular carrier Macromolecules Medical sciences methotrexate Natural polymers Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Physicochemistry of polymers Polyamides polymer-drug conjugation Proteins Purification Reaction kinetics Solubility Water |
title | Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A07%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carrier-bound%20methotrexate.%20I.%20Water-soluble%20polyaspartamide-methotrexate%20conjugates%20with%20ester%20links%20in%20the%20polymer-drug%20spacer&rft.jtitle=Journal%20of%20applied%20polymer%20science&rft.au=Meirim,%20M.%20G.&rft.date=2001-11-21&rft.volume=82&rft.issue=8&rft.spage=1844&rft.epage=1849&rft.pages=1844-1849&rft.issn=0021-8995&rft.eissn=1097-4628&rft.coden=JAPNAB&rft_id=info:doi/10.1002/app.2027&rft_dat=%3Cproquest_cross%3E582407%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21470103&rft_id=info:pmid/&rfr_iscdi=true |